Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer by Cronin, SJF, Rao, S, Tejada, MA, Turnes, BL, Licht-Mayer, S, Omura, T, Brenneis, C, Jacobs, E, Barrett, L, Latremoliere, A, Andrews, N, Channon, KM, Latini, A, Arvanites, AC, Davidow, LS, Costigan, M, Rubin, LL, Penninger, JM, Woolf, CJ

Crucial neuroprotective roles of the metabolite BH4 in dopaminergic neurons by Cronin, SJF, Yu, W, Hale, A, Licht-Mayer, S, Crabtree, MJ, Korecka, JA, Tretiakov, EO, Sealey-Cardona, M, Somlyay, M, Onji, M, An, M, Fox, JD, Turnes, BL, Gomez-Diaz, C, da Luz Scheffer, D, Cikes, D, Nagy, V, Weidinger, A, Wolf, A, Reither, H, Chabloz, A, Kavirayani, A, Rao, S, Andrews, N, Latremoliere, A, Costigan, M, Douglas, G, Freitas, FC, Pifl, C, Walz, R, Konrat, R, Mahad, DJ, Koslov, AV, Latini, A, Isacson, O, Harkany, T, Hallett, PJ, Bagby, S, Woolf, CJ, Channon, KM, Je, HS, Penninger, JM